Consumer Research
SNDL Reports Q2 2026 Financial and Operational Results
EDMONTON – SNDL Inc. announced the completion of assets acquisition ...
IRS Pushes Back on Cannabis Tax Refund Claims as the 280E Battle Enters a New Era
WASHINGTON, D.C.-The Cannabis industry's long-running battle with Section 280E has ...
Ascend Wellness Seeks Shareholder Approval for Reverse Stock Split Ahead of Potential Uplisting
NEW YORK – Ascend Wellness Holdings Inc., a vertically integrated multistate Cannabis operator, is preparing for a possible move to a major U.S. stock exchange. The company has filed documents outlining a shareholder vote on ...
The Real Operational Cost of Cash Discrepancies in High-Volume Dispensaries
LOS ANGELES – Cannabis dispensaries occupy a distinctive position in American retail. They are among the highest-grossing single-location stores in the country, processing thousands of transactions per day, yet the majority remain locked out of ...
Psychedelic Alpha Partners with Horizons to Present The Psychedelic Business Forum
NEW YORK – The Psychedelic Business Forum, Horizons: Perspectives on Psychedelics, returns to the New York Academy of Medicine on October 15, 2026, with Psychedelic Alpha formalized this year as a co-presenter alongside Horizons. Horizons ...
Germany Puts “GMP Washing” in Medical Cannabis on Notice
BERLIN – Germany's Hessian State Office for Health and Care (HLfGP) published a formal guidance document targeting the widespread practice of "GMP washing", i.e. importing Cannabis flowers from third-country cultivators under Good Agricultural and Collection ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered the most jam-packed period of meaningful news our sector has seen in 2026. Federal rescheduling hearings opened. Virginia finally locked in its retail framework. Definium posted the cleanest ...
Lazear Advises Medical Cannabis Company Organic Remedies on ESOP Transaction
COLUMBUS, Ohio, July 6, 2026 – Organic Remedies, one of Pennsylvania's leading medical cannabis companies, has completed its transition to 100% employee ownership through an Employee Stock Ownership Plan (ESOP), marking another milestone in the ...
Q2 2026: The Quarter That Counted For Psychedelics
LOS ANGELES – Q2 2026 gave the psychedelic medicine sector the quarter that practitioners, investors, and regulators had been building up for years. Clinical programs delivered Phase 3 results, the White House signed an executive ...
Germany Puts “GMP Washing” in Medical Cannabis on Notice
BERLIN – Germany's Hessian State Office for Health and Care (HLfGP) published a formal guidance document targeting the widespread practice of "GMP washing", i.e. importing Cannabis flowers from third-country cultivators under Good Agricultural and Collection ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered the most jam-packed period of meaningful news our sector has seen in 2026. Federal rescheduling hearings opened. Virginia finally locked in its retail framework. Definium posted the cleanest ...
Lazear Advises Medical Cannabis Company Organic Remedies on ESOP Transaction
COLUMBUS, Ohio, July 6, 2026 – Organic Remedies, one of Pennsylvania's leading medical cannabis companies, has completed its transition to 100% employee ownership through an Employee Stock Ownership Plan (ESOP), marking another milestone in the ...
Rubicon Organics Reports Q1 2026 Financial Results
VANCOUVER – Rubicon Organics Inc. delivered its first-quarter report, revealing results that show both progress and short-term pressures common in an industry shifting toward larger-scale operations – all while balancing strong market share gains with ...
BREAKING: Colorado Passes Landmark Ibogaine Research Bill, Expanding the State’s Natural Medicine Framework
DENVER- Colorado has taken another major step in the evolution of regulated psychedelic medicine. The Colorado legislature has passed House Bill 26-1325, a landmark measure that establishes an ibogaine research pilot program within the state’s ...
The DEA Window: The Real Fight Is Over Who Qualifies as Medical Cannabis
WASHINGTON, D.C. - The real significance of the DEA window is not that the Cannabis industry needs another explanation of legalization. Operators, investors, attorneys, and regulators already understand the limits of federal reform. The more ...
Study: Older Americans Are Turning to Cannabis as an Alternative to Pharmaceuticals
NEW YORK - Older Americans are increasingly looking at Cannabis not as a lifestyle product, but as a practical alternative to traditional pharmaceuticals. A new study highlighted by NORML points to a growing trend among ...
Definium Doses First Patient in Second Phase 3 LSD-Based Trial
NEW YORK – Definium Therapeutics Inc. has taken another step forward in its late-stage testing of a psychedelic-derived treatment for major depressive disorder. The company announced that the first participant received a dose in the ...
Glass House Brands Reports Q1 2026 Financial Results
LONG BEACH – Glass House Brands Inc. released its first-quarter earnings for 2026, showing revenue slightly ahead of internal expectations but down from the year-ago period, with profitability pressured by higher costs and soft wholesale ...
Planet 13 Reports Q1 2026 Financial Results
LAS VEGAS – Planet 13 Holdings Inc. released its first-quarter 2026 financials, reflecting the effects of substantial operational changes and declines in top-line figures, yet showcasing margin gains and cost controls as indications of progress ...
MariMed Reports Q1 2026 Financial Results
NORWOOD – MariMed Inc. turned in another quarter of measured progress in a tough Cannabis market. The company, with operations spanning cultivation, production, and retail facilities across multiple states, has reported year-over-year revenue growth and ...
Grown Rogue Reports Q1 2026 Financial Results
MEDFORD – Grown Rogue International Inc. delivered solid top-line gains in the opening months of 2026, underscoring its push into select markets while managing pressures in more established ones. The company, known for its focus ...
Jushi Reports Q1 2026 Financial Results
BOCA RATON – Jushi Holdings Inc. delivered a quarter of steady operational progress while facing ongoing industry pressures. The multi-state operator recorded year-on-year improvements in revenue and profitability metrics, and completed a significant refinancing of ...
iAnthus Reports Q1 2026 Financial Results
NEW YORK-TORONTO – iAnthus Capital Holdings posted its fiscal first-quarter results for 2026, revealing a company focused on operational tweaks while navigating softer sales in a competitive Cannabis market. The multi-state operator, active across retail ...
Organigram Reports Q2 Fiscal 2026 Results
TORONTO – Organigram Global Inc. released its financial results, marking a quarter shaped by shifts in consumer preferences and execution issues in key categories. The Canadian producer, known for holding the top market share position ...
Cannabis 3.0: From Getting High to Getting Clinical
NEW YORK-Cannabis is entering a new phase, and this one is about much more than consumption. For decades, Cannabis was trapped in prohibition and treated mainly as a legal problem. Then came commercialization, when Cannabis ...
Vireo Growth Reports Q1 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. released its first-quarter 2026 financial results, highlighting the early effects of an active acquisition strategy that has broadened its operations across several key Cannabis markets. The company, which operates a ...
Village Farms Reports Q1 2026 Financial Results
VANCOUVER – Village Farms International Inc., known for its large-scale greenhouse operations, reported gains in revenue and profitability driven largely by exports. Consolidated net sales climbed 27% year-over-year to $50.2 million, with net income attributable ...
Israeli Cannabis Breakthrough Opens New Hope for Fatty Liver Disease
NEW YORK- A new study out of Israel has put Cannabis back into one of the most important conversations in modern medicine: metabolic disease. Researchers at the Hebrew University of Jerusalem have reported that two ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The ...
Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine
NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune ...
Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine
NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of ...
Cresco Labs Reports Q1 2026 Financial Results
CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...
Cronos Group Reports Q1 2026 Financial Results
TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC ...
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA Commissioner Martin A. Makary urging the agency to move faster on ongoing reviews of psychedelic treatments. The letter stated that ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the ...
